Opicapone for the treatment of Parkinson’s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Opicapone for the treatment of Parkinson’s disease

Published:2017-02-22 Issue:4 Volume:18 Page:445-453
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Rodrigues Filipe B¹²³,Ferreira Joaquim J¹²⁴

Affiliation:

1. Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisboa, Portugal

2. Clinical Pharmacology Unit, Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon, Lisbon, Portugal

3. Huntington’s Disease Centre, Institute of Neurology, University College London, London, UK

4. CNS - Campus Neurológico Sénior, Torres Vedras, Portugal

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1294683

Reference67 articles.

1. Epidemiology of Parkinson's disease

2. 100 years of Lewy pathology

3. Parkinson's Disease and Parkinsonism: Neuropathology

4. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

5. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opicapone as an add-on to levodopa for reducing end-of-dose motor fluctuations in Parkinson’s disease: a systematic review and meta-analysis;Journal of Comparative Effectiveness Research;2022-08

2. Guidelines for Parkinson’s disease treatment: consensus from the Movement Disorders Scientific Department of the Brazilian Academy of Neurology - motor symptoms;Arquivos de Neuro-Psiquiatria;2022-03

3. Metabolism and disposition of opicapone in the rat and metabolic enzymes phenotyping;Pharmacology Research & Perspectives;2021-12-22

4. Opicapone Protects Against Hyperhomocysteinemia-Induced Increase in Blood–Brain Barrier Permeability;Neurotoxicity Research;2021-10-28

5. Emerging Pharmacotherapies for Motor Symptoms in Parkinson’s Disease;Journal of Geriatric Psychiatry and Neurology;2021-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3